LEF1

protein-coding

lymphoid enhancer binding factor 1, the group of TCF/LEF transcription factor family|Wnt enhanceosome complex

Gene summary

This gene encodes a transcription factor belonging to a family of proteins that share homology with the high mobility group protein-1. The protein encoded by this gene can bind to a functionally important site in the T-cell receptor-alpha enhancer, thereby conferring maximal enhancer activity. This transcription factor is involved in the Wnt signaling pathway, and it may function in hair cell differentiation and follicle morphogenesis. Mutations in this gene have been found in somatic sebaceous tumors. This gene has also been linked to other cancers, including androgen-independent prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]

MANE transcript

NM_016269.5

Inheritance

AD, AR

ClinVar variants

P:4U:59B:4

Top phenotype

ectodermal dysplasia 17 with or without limb malformations

gnomAD constraint

pLI —, LoF o/e 0.04

Max pathogenic AF

—

Genomic locus

chr4:108,047,545-108,168,956

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~121.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

ectodermal dysplasia 17 with or without limb malformationsSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0979228

Submitter: PanelApp Australia

ectodermal dysplasia 17 with or without limb malformationsLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0979228

Submitter: PanelApp Australia

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to LEF1 variants in ClinVar

7 Conditions Cataloged
not specifiedTotal: 45
not providedTotal: 11
Ectodermal dysplasia 17 with or without limb malformationsTotal: 6
EctrodactylyTotal: 2
LEF1-related disorderTotal: 1
Radial ray deficiencyTotal: 1
Ectrodactyly and ectodermal dysplasia without cleft lip/palateTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_016269.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
2
clinvar
1
clinvar
5
missense
49
clinvar
1
clinvar
50
nonsense
2
clinvar
2
start loss
0
frameshift
2
clinvar
2
clinvar
4
splice donor/acceptor (+/-2bp)
6
clinvar
6
Total22593167
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 31 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_016269.5RefSeqNP_057353.111MANE Select
ENST00000265165.6EnsemblENSP00000265165.111MANE Select
NM_001130713.3RefSeqNP_001124185.110Standard
NM_001130714.3RefSeqNP_001124186.110Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
lef1Danio rerio

Structure: melanocyte

Quality: decreased amount

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Gastric cancer - Homo sapiens (human)
  • Adherens junction - Homo sapiens (human)
  • Cushing,s syndrome - Homo sapiens (human)
  • Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human)
  • Acute myeloid leukemia - Homo sapiens (human)

Biological Process

  • negative regulation of transcription by RNA polymerase II
  • branching involved in blood vessel morphogenesis
  • osteoblast differentiation
  • somitogenesis
  • epithelial to mesenchymal transition

Molecular Function

  • RNA polymerase II regulatory region sequence-specific DNA binding
  • RNA polymerase II proximal promoter sequence-specific DNA binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA-binding transcription activator activity, RNA polymerase II-specific
  • DNA binding

Cellular Component

  • nucleus
  • nucleoplasm
  • transcription factor complex
  • cytoplasm
  • protein-DNA complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000265165
Coding exons
11
Length
121412
Individuals with no LoFs
125742
Homozygous LoFs
0
Heterozygous LoFs
5
Defined
125747
p
0.0000199
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.571672350.7110.00001192619
Missense (PolyPhen)71120.240.590471386
Synonymous0.2828689.40.9620.00000521750
Loss of Function4.19122.40.04469.49e-7277

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian0.000110.00011rare
Finnish00.0absent
European (Non-Finnish)0.0000260.000026rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Participates in the Wnt signaling pathway. Activates transcription of target genes in the presence of CTNNB1 and EP300. May play a role in hair cell differentiation and follicle morphogenesis. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by LEF1 and CTNNB1. Regulates T-cell receptor alpha enhancer function. Binds DNA in a sequence-specific manner. PIAG antagonizes both Wnt-dependent and Wnt-independent activation by LEF1 (By similarity). Isoform 3 lacks the CTNNB1 interaction domain and may be an antagonist for Wnt signaling. Isoform 5 transcriptionally activates the fibronectin promoter, binds to and represses transcription from the E-cadherin promoter in a CTNNB1- independent manner, and is involved in reducing cellular aggregation and increasing cell migration of pancreatic cancer cells. Isoform 1 transcriptionally activates MYC and CCND1 expression and enhances proliferation of pancreatic tumor cells. {ECO:0000250, ECO:0000269|PubMed:11266540, ECO:0000269|PubMed:19653274, ECO:0000269|PubMed:2010090}.;

Recessive Scores

pRec
0.832

Intolerance Scores

LoFtool
0.0162
RVIS EVS
0.2
RVIS percentile EVS
67.19

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.988

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.